Skip Navigation
request an appointment my chart notification lp musc-logo-white-01 facebook twitter youtube blog find a provider circle arrow
MUSC mobile menu

Radiation Oncology Blog

A Blog for Radiation Oncology
Date: Apr 2015

Oral, Head and Neck Cancer Awareness Week, a time recently recognized by patients and organizations around the country, focuses on promoting education around these types of cancer, screening methods for early detection and treatment approaches.Cancer Awareness

At MUSC, the Head and Neck Tumor Center offers services for patients diagnosed with tumors in the following areas:

  • Neck
  • Mouth
  • Thyroid
  • Throat/larynx
  • Pituitary gland
  • Saliva glands
  • Ear
  • Eye
  • Nose

A multidisciplinary approach involving more than 30 specialists provides comprehensive expertise and recommendations to patients on the best course of treatment for their individual diagnosis.

If you or a loved one has been diagnosed with an oral, head or neck cancer, contact us to schedule a consultation and learn about your treatment options.

April is recognized annually as National Cancer Control Month, a time to draw attention to advances made in the fight against cancer and raise awareness for prevention and screening methods for early detection.Lung Cancer

Lung cancer in particular is one area in which screening techniques have received increased attention and support for their role in early detection of disease in high-risk patients.

The Centers for Medicare and Medicaid Services (CMS) recently announced that screenings for lung cancer with low dose computed tomography (LDCT) will now be covered by Medicare.

A long-awaited decision, this is the first time Medicare has covered lung cancer screening and is important news for Medicare patients seeking preventive services.

Medicare beneficiaries who meet the required criteria will be eligible for annual lung cancer screenings with LDCT. To be eligible, patients must meet all criteria outlined in the official announcement available here.

Coverage includes a counseling visit and shared decision-making on the benefits and risks of lung cancer screening. A key goal of low-dose CT screening for lung cancer is detection of early stage disease, when the cancer is more likely not to have spread and is typically considered easier to treat.

If you or a loved one is screened for lung cancer and the disease is detected, contact us to learn about treatment options available through Hollings Cancer Center and MUSC’s Thoracic Oncology program. Click here to request an appointment.


Treatment of breast cancer and prostate cancer is a key focus for MUSC physicians treating patients at Hollings Cancer Center’s Mount Pleasant location.

In February, an open house event was held for the community to unveil new technology that offers improved imaging capabilities for patients, as well as several types of external beam radiation therapy. TrueBeamTM is an advanced cancer treatment system offering the latest radiation therapy techniques, including new imaging features that increase precision and accuracy of radiation delivery.Dr. Jennifer Harper

Dr. Jennifer Harper, MUSC associate professor and radiation oncologist, sees patients regularly at Hollings Cancer Center Mt. Pleasant. She says, “The new TrueBeam system in Mt. Pleasant reflects our commitment to ensure patients are treated with the most advanced technology supported by clinical research and provides another access point for patients and their families to get expertise from MUSC physicians in a community location.”

The availability of other important cancer services such as mammograms in the Mt. Pleasant community nicely complement the treatment services the cancer center offers. Dr. Harper anticipates Hollings Cancer Center Mt. Pleasant will evolve into a destination for breast and prostate cancer treatment.

To learn more about treatment services at Hollings Cancer Center Mt. Pleasant, call 843-876-8411 or request an appointment here.

Dr. David Marshall, a radiation oncologist at MUSC Hollings Cancer Center, made a recent visit to WCIV-TV’s Lowcountry Live! show to discuss technology advancements at the cancer center, as well as an overview of active clinical trials open to patients.

Dr. Marshall serves as Deputy Associate Director of Clinical Investigations at Hollings Cancer Center. Watch the video below to hear from him.